study of the nematode Caenorhabditis elegans has provided important insights in a wide range of fields in biology. the ability to precisely modify genomes is critical to fully realize the utility of model organisms. here we report a method to edit the C. elegans genome using the clustered, regularly interspersed, short palindromic repeats (crisPr) rnA-guided cas9 nuclease and homologous recombination. We demonstrate that cas9 is able to induce dnA double-strand breaks with specificity for targeted sites and that these breaks can be repaired efficiently by homologous recombination. By supplying engineered homologous repair templates, we generated gfp knock-ins and targeted mutations. together our results outline a flexible methodology to produce essentially any desired modification in the C. elegans genome quickly and at low cost. this technology is an important addition to the array of genetic techniques already available in this experimentally tractable model organism.
The ability to precisely modify the genome of an organism by adding, deleting or mutating genes is a critical tool for experimental biology. The type II CRISPR-associated (Cas) system is a powerful tool for genome editing in a variety of experimental systems. The Cas9 nuclease and two small noncoding RNAs comprise an adaptive immune system in prokaryotes 1 . A chimeric fusion of the two RNAs, termed a single guide RNA (sgRNA), supports site-specific cleavage of target DNA by Cas9, with target specificity determined by base-pairing between the 5′ end of the sgRNA and the target DNA 1 (Fig. 1a) . The only specific sequence requirement for cleavage is an NGG nucleotide sequence (the protospacer adjacent motif) at the 3′ end of the target DNA sequence (Fig. 1a) . Changing the targeting sequence at the 5′ end of the sgRNA can allow an exceptionally broad variety of DNA substrates to be targeted without the need to reengineer the Cas9 nuclease [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] . Compared to zinc-finger nucleases and transcription activator-like effector nucleases (TALENs) that can be used to produce double-strand breaks 14 , the CRISPR-Cas9 system is substantially less expensive and is easier to program for new target sites. Cas9 has been used to produce targeted insertion or deletion (indel) mutations, which are generated via error-prone engineering the Caenorhabditis elegans genome using cas9-triggered homologous recombination repair mechanisms, in a wide range of species [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] . In addition, homology-directed repair of Cas9-induced double-strand breaks has been demonstrated in bacteria 7 , yeast 3 , cultured human and mouse cells 5, 11 , fruit flies 4 , zebrafish 10 and mice 13 .
The nematode C. elegans is a valuable and widely used experimental system owing to its rapid growth, ease of handling and transparency (which facilitates microscopy). Recent reports demonstrated that Cas9 can induce double-strand breaks in the C. elegans germ line, which leads to mutations via errorprone repair mechanisms 8, 15 . Here we demonstrate that Cas9induced double-strand breaks can be repaired efficiently by homologous recombination. By supplying engineered homologous repair templates, we generated in-frame gfp insertions and targeted mutations. We refer to this method as Cas9-triggered homologous recombination.
results design of a crisPr-cas9 system for C. elegans
To establish Cas9 as a tool for genome editing in C. elegans, we expressed Cas9 and sgRNA in the C. elegans germ line. In mammalian systems, sgRNAs were expressed from a U6 small nuclear RNA promoter, which drives transcription by RNA polymerase III 5, 11 . To our knowledge, no germline RNA polymerase III promoters had been described in C. elegans when we initiated these experiments. Aligning ten C. elegans U6 genes revealed a region of 200-300 base pairs (bp) upstream of the transcriptional start site that is partially conserved and may function as the promoter ( Fig. 1b and Supplementary Fig. 1 ). We therefore expressed sgRNAs using 350 bp upstream of the highly expressed R07E5.16 U6 gene 16 . A different U6 promoter was independently identified by Friedland et al. 8 . To express Cas9 in the germ line, we used the eft-3 promoter and tbb-2 3′ UTR, which have been used successfully for genome modifications employing the Mos1 transposon 17 . We built a Cas9-sgRNA plasmid containing both the Peft-3øCas9øtbb-2-3′ UTR and PU6øsgRNA constructs ( Fig. 1c) . This plasmid, available through Addgene, can be engineered to target any desired sequence by using site-directed mutagenesis to insert the appropriate targeting sequence.
homologous repair of cas9-induced double-strand breaks
Several existing methods for modifying the C. elegans genome rely on homologous repair of double-strand breaks generated by excision of a Mos1 transposon [18] [19] [20] [21] , but these techniques are limited by the relative scarcity of Mos1 insertion sites in the genome 22 . In principle, a much wider range of genome modifications could be made by using Cas9 to generate double-strand breaks. We therefore tested whether Cas9-induced double-strand breaks could be repaired by homologous recombination in C. elegans. We designed an sgRNA targeting a sequence adjacent to the ttTi5605 Mos1 insertion site on chromosome II and compared the efficiency of singlecopy transgene insertion into this site using either Mos1-mediated single-copy insertion (MosSCI 20 ) or Cas9-triggered homologous recombination ( Fig. 2a) . The efficiency of both approaches varied among individual experiments, but the overall efficiency of the two methods was similar ( Fig. 2b and Supplementary Table 1 ). We examined expression of the resulting single-copy gfp transgenes under the control of the mex-5 promoter and tbb-2 3′ UTR. The transgenes were expressed in the germ line, and the pattern of expression was indistinguishable regardless of the method used for transgene insertion (Fig. 2c) . These data demonstrate that Cas9-induced double-strand breaks can stimulate homologous recombination in the C. elegans germ line.
integration of gfp into endogenous loci
In C. elegans, fluorescent fusion proteins are often expressed via microinjection of DNA into the gonad, which generates semistable extrachromosomal arrays that contain many copies of the injected DNA 23 . Transgenes generated in this way are typically overexpressed in somatic tissues and silenced in the germ line and early embryo 24 . Microparticle bombardment can be used to generate low-copy transgenes, which are expressed at closer to endogenous levels 25, 26 , but this approach is expensive and time consuming. MosSCI can be used to generate single-copy transgenes 20 , but for many genes, the regulatory sequences needed to recapitulate the native expression pattern are unknown. All of these approaches also leave the endogenous copy of the gene of interest intact, which makes it difficult to assess the function of the fusion protein genetically and can introduce complications in quantitative experiments because less than 100% of molecules of the protein of interest are labeled. Inserting genetically encoded tags To test whether Cas9-triggered homologous recombination could be used to insert protein tags into endogenous genes, we targeted the nmy-2 gene, which encodes nonmuscle myosin II ( Fig. 3) . We built a homologous repair template comprising the C-terminal 1.5 kilobases (kb) of nmy-2 fused in-frame to gfp, which was followed by the nmy-2 3′ UTR, an unc-119(+) selectable marker and 1.5 kb of downstream genomic sequence (Fig. 3a) . The unc-119(+) gene was flanked by loxP sites, which allowed it to be removed by subsequent expression of Cre recombinase. We also generated a Cas9-sgRNA plasmid targeted to cleave at the 3′ end of nmy-2. Co-injection of the Cas9-sgRNA plasmid and homologous repair template into unc-119 worms resulted in integration of gfp and unc-119(+) into the 3′ end of the nmy-2 locus (three independent knock-in alleles from 60 total injected animals). We confirmed the correct integration of gfp at the 3′ end of the nmy-2 gene in all three lines by PCR ( Fig. 3b ) and sequencing.
We examined the expression and localization of the NMY-2-GFP fusion protein in these three homozygous knock-in lines. For comparison, we analyzed a strain carrying zuIs45, a wellestablished transgene generated by microparticle bombardment 27 . The knock-in strains expressed NMY-2-GFP at levels similar to those of endogenous NMY-2, whereas the zuIs45 strain expressed NMY-2-GFP at lower levels ( Fig. 3d) . NMY-2-GFP localized to the cell cortex in nmy-2øgfp knock-in embryos, with a pattern that was indistinguishable from that in embryos carrying zuIs45 npg ( Fig. 3e and Supplementary Video 1) . However, the knock-in embryos showed consistently brighter fluorescence, which is consistent with the higher expression of NMY-2-GFP in the knock-ins.
Because nmy-2 is an essential gene 28 , we tested whether gfp insertion disrupted protein function by assaying for lethality. Two of three nmy-2øgfp knock-in strains were 100% homozygous viable, and a third strain was 99% viable (n > 100 embryos for each strain). Animals of all three knock-in strains displayed wild-type movement and had no discernable phenotypes. We conclude that insertion of gfp at the endogenous locus does not affect nmy-2 gene function.
For some applications, the insertion of the unc-119(+) selectable marker into the genome may be problematic. We therefore developed a simple procedure to remove the unc-119(+) marker by injecting a plasmid encoding Cre recombinase under the control of the eft-3 promoter and tbb-2 3′ UTR (Online Methods) and picking uncoordinated (Unc) worms from the F 2 progeny (Fig. 3c) . We isolated Unc animals in 5 of 5 independent experiments (12-20 animals injected in each experiment). The high success rate achieved with relatively few injected animals indicates that Cre-mediated excision of unc-119(+) is highly efficient. We then outcrossed to wild-type worms to remove the unlinked unc-119 mutation required for unc-119(+) selection. This resulted in a strain containing no known genomic modifications except for insertion of gfp into the nmy-2 gene and a 34-bp loxP site in the intergenic region downstream of nmy-2 (Fig. 3a) . NMY-2-GFP expression in these animals was not altered by removal of the unc-119(+) selection marker (data not shown), suggesting that this marker does not affect fluorescent fusion protein expression when it is inserted into an intergenic region.
To test whether this strategy is likely to be broadly applicable, we used a similar approach to endogenously tag the his-72 gene, which encodes histone H3, with GFP. We obtained one knockin strain from ten successfully injected animals. We were able to amplify the left and right insertion junctions, confirming insertion of gfp into the his-72 locus (Fig. 4a) . However, we were unable to amplify across the insertion, and a more detailed PCR characterization showed that a rearrangement involving a duplication of the unc-119(+) cassette had occurred (data not shown). Such rearrangements have been reported to occur in other studies involving homologous recombination 20, 29 and occurred at a low frequency in our study (1 of 16 strains generated by Cas9triggered homologous recombination, 1 of 7 MosSCI strains). Of note, his-72 mRNA levels in the his-72øgfp knock in-strain were indistinguishable from those of wild type, indicating that the rearrangement did not affect the his-72 gene itself (Fig. 4b) . These animals were healthy and showed bright nuclear GFP fluorescence in a wide range of tissues including the germ line, consistent with labeling of endogenous histone (Fig. 4c) .
Generation of multiple point mutations in a single step
Another application of Cas9-triggered homologous recombination is the generation of targeted mutations at endogenous loci. To demonstrate this, we made mutations in lin-31, which encodes a FOXB transcription factor required for vulval development 30 . LIN-31 forms a complex with a LIN-1 (a homolog of mammalian Ets transcription factor), and this complex is thought to repress the primary vulval fate 31 . MPK-1, a mitogen-activated protein kinase (MAPK), can phosphorylate LIN-31 on four C-terminal threonines, and addition of active MAPK disrupts the interaction between LIN-31 and LIN-1 in vitro 31 . Overexpression of nonphosphorylatable LIN-31 causes a vulval phenotype 31 , but whether MAPK phosphorylation affects the function of endogenous LIN-31 has not been tested directly.
We used Cas9-triggered homologous recombination to mutate the four MAPK phosphorylation sites at the C terminus of LIN-31 to either alanine (nonphosphorylatable) or glutamic acid (phosphomimetic) ( Fig. 5a,b) . We used a Cas9-sgRNA plasmid targeting a site 5′ of these four residues to ensure that the Unc-119(+) animals we isolated would contain mutations at all four sites ( Fig. 5b) . We obtained two independent lin-31(4T→A) alleles from 60 total injected animals and three independent lin-31(4T→E) alleles from 62 total injected animals. We confirmed the desired mutations by PCR (not shown) and sequencing (Fig. 5c) .
Mutation of the four MAPK phosphorylation sites to alanine caused a distorted vulval morphology at the L4 stage and a partially penetrant protruding vulva phenotype in the adult. A similar phenotype was observed when these residues were mutated to glutamic acid, mimicking constitutive phosphorylation (Fig. 5d,e and Supplementary Table 2 ). Identical phenotypes were observed for two independently isolated lin-31(4T→A) lines and for three independently isolated lin-31(4T→E) lines. These results suggest that dynamic regulation of LIN-31 phosphorylation is important for normal vulval development.
Assessment of cas9 specificity in C. elegans
Cas9 has been reported to produce off-target mutations in mammalian cells, which raises concerns about the specificity of this enzyme in genome-editing applications 32 . To assess the specificity of Cas9 in C. elegans, we identified the genomic sequences most similar to the targeting sequences that we used to modify nmy-2 npg and lin-31. We focused on candidate offtarget sequences that closely matched the 3′ end of our targeting sequences, as Cas9 activity has been shown to be most sensitive to mismatches in the 3′ half of sgRNA targeting sequences 1, 5, 7, 32 . We PCR-amplified and sequenced ten candidate off-target sites for the nmy-2 sgRNA and four for the lin-31 sgRNA ( Supplementary Table 3 ). We found no mutations at any of these sites in any of the strains we isolated. We note that although Fu et al. detected off-target activity of Cas9 toward sequences with up to five mismatches to the sgRNA sequence 32 , the closest matches that existed to our nmy-2 and lin-31 sgRNAs contained six or more mismatches each (Supplementary Table 3 ). The small size of the C. elegans genome compared to that of mammalian genomes may reduce the odds of closer off-target matches to particular target sequences.
discussion
We have demonstrated a method to efficiently induce essentially any desired modification in the C. elegans genome. This approach was robust and cost-effective: for example, we obtained three independent nmy-2øgfp knock-in lines from a single set of injections, requiring less than 4 weeks total time (of which less than 2 d was handson time) and less than $200 worth of materials ( Supplementary  Fig. 2 and Supplementary Protocol) . In 6 of 8 experiments, we obtained multiple independent lines on the first attempt. In the other two cases, the first set of injections failed for trivial technical reasons (Online Methods), and we readily obtained homologous recombinants upon reinjection. Thus, we achieved an overall success rate of 100% without extensive reengineering or optimization, which implies that our strategy is likely to be broadly applicable. In addition, the ability to remove the selectable marker in a single step using Cre recombinase should facilitate the use of unc-119 or other selectable markers for a wide variety of genome-editing strategies. Our method relies on double-strand break repair using an engineered homologous template, similar to earlier methods that used Mos1 transposon excision to generate double-strand breaks [18] [19] [20] [21] . The use of Cas9 in our system overcomes several important limitations of Mos1-based methods. First, Cas9 target sites occur once every 32 bp in random DNA sequence; we estimate that there are over 1 million potential Cas9 target sites in the C. elegans genome, compared to approximately 14,000 Mos1 insertion sites 22, 33 . This greatly expands the range of modifications that can be made because homologous recombination is most efficient within 0.5 kb of a double-strand break 18 . Indeed, none of the alleles presented in this study could have been made using Mos1based methods because appropriate transposon insertion alleles do not exist. Second, by carefully choosing the positions of the Cas9 cleavage site and selectable marker relative to the desired modification, the investigator can ensure that the desired genome modification is present in every isolated recombinant ( Fig. 5b  and Supplementary Protocol) , in contrast to Mos1-based methods, in which the length of a gene conversion track is stochastic and decays rapidly with increasing distance from the transposon insertion site 18 . Third, Cas9 could in principle be used in any genetic background, whereas Mos1-based genome modifications must be generated in a strain carrying a Mos1 insertion. Finally, mobilization of Mos1 generates an average of 2-3 new Mos1 insertions at random sites elsewhere in the genome 33, 34 , which could cause undesired phenotypes.
Cas9-triggered homologous recombination also has advantages over conventional transgenic approaches for generating fluorescent-protein fusions. Generating and maintaining a knockin line with our approach is cheaper and less labor intensive than either microparticle bombardment or extrachromosomal arrays. Also, it is expected to maintain the endogenous pattern of expression in most cases, and fusion-protein function can be easily assessed genetically owing to the absence of untagged protein. Knock-in strategies are the standard approach for generating fluorescent-protein fusions in yeast for these reasons, and our methodology will allow widespread application of this approach in C. elegans.
Despite these advantages, there are some potential limitations associated with the use of Cas9-triggered homologous recombination to endogenously tag genes. First, fusion of gfp to the 3′ end of a gene may compromise protein function, though this can be detected if it causes a loss-of-function phenotype. Second, GFP-coding sequences are sometimes recognized as 'nonself ' and silenced by the Piwi Argonaute RNA pathway 35 . Such a silencing event should again be detectable if it produces a loss-of-function phenotype and/or loss of GFP fluorescence. Third, the DNA repair mechanism involved in homologous recombination can sometimes generate complex rearrangements, as we observed for his-72øgfp 20, 29 . Because these events are uncommon, a straightforward solution is to isolate multiple knock-in alleles for each gene of interest. We obtained multiple independent alleles from a single set of injections for 7 of the 8 Cas9-triggered homologous recombination experiments performed for this study (his-72øgfp was the exception). Finally, for some genes with low endogenous expression levels, fluorescence of gfp knock-ins may be too dim to visualize. Development of brighter fluorescent proteins [36] [37] [38] may facilitate knock-in approaches for genes with lower endogenous expression levels. If fluorescence in a knock-in strain is too dim to be useful, then the investigator may choose to use an overexpression strategy, accepting the caveat that overexpression artifacts are possible.
In using Cas9-triggered homologous recombination to generate targeted mutations in endogenous genes, we chose to make point mutants; but we expect that insertions, deletions or other modifications could be made with similar ease, as has been done previously using Mos1 excision 20, 21 . Of note, single point mutants have also been made in C. elegans using TALEN cleavage and ssDNA oligo-mediated repair 15 , but this approach is limited by the length of a synthetic DNA oligonucleotide and would have required at least two sequential injection steps to produce the four lin-31 point mutations that we were able to generate in a single step.
Interestingly, the phenotype we observed in lin-31 mutants was different from that reported by Tan et al. 31 , who found that expression of lin-31(4T→A) from an extrachromosomal array inhibited vulval fate specification. We suggest that repression of vulval fate in earlier experiments may have been due to overexpression of LIN-31 protein rather than solely its inability to be phosphorylated by MPK-1. The ability to quickly and efficiently induce mutations in endogenous genomic loci renders the use of multicopy extrachromosomal arrays unnecessary and should greatly simplify the interpretation of reverse genetic experiments.
In summary, we have developed a flexible, inexpensive and robust strategy for genome editing in C. elegans using Cas9 targeted cleavage and homologous recombination. Given the ease with which our approach can be adapted to new targets, we suggest that the ability to modify the C. elegans genome is now limited only by the imagination of the investigator.
methods
Methods and any associated references are available in the online version of the paper. Accession codes. Addgene: Cas9-sgRNA plasmid targeting a site near ttTi5605, 47550; Cas9-sgRNA plasmid with no targeting sequence, 47549; Peft-3øCreøtbb-2-3′ UTR construct, 47551.
Note: Any Supplementary Information and Source Data files are available in the online version of the paper. online methods Strains and nomenclature. New genetic nomenclature for genome editing applications has been developed by the WormBase Gene Name Curators (J. Hodgkin, University of Oxford, and T. Schedl, Washington University School of Medicine, personal communication). Briefly, edited loci are assigned conventional allele designations, with the nature of the modification described in brackets after the allele name. For example, one of our nmy-2øgfp knockin alleles is nmy-2(cp7[nmy-2øgfp + LoxP unc-119(+) LoxP]) I, and a lin-31 mutant lin-31(cp2[T145A T200A T218A T220A + LoxP unc-119(+) LoxP]) II. Note that each independently isolated mutant line is given its own allele designation, even if the molecular lesion is identical. When the unc-119(+) selectable marker has been removed using Cre recombinase, a new allele designation is assigned. For example, an nmy-2øgfp knock-in allele with the unc-119(+) cassette removed is designated nmy-2(cp13[nmy-2øgfp + LoxP]) I. The cp13 allele was derived from cp7 by Cre-mediated recombination.
Supplementary Table 4 lists all strains generated and used in this study. All strains were kept at 25 °C and fed Escherichia coli strain OP50 except where noted below and were handled using standard techniques 39 .
Plasmid construction. Plasmids have been deposited in Addgene with the following accession numbers: Cas9-sgRNA plasmid targeting a site near ttTi5605, 47550; Cas9-sgRNA plasmid with no targeting sequence, 47549; and the Peft-3øCreøtbb-2-3′ UTR construct, 47551. All other plasmids used in this study are available from the authors upon request.
To construct the Cas9-sgRNA expression plasmid shown in Figure 1c , we first designed a synthetic gene encoding Cas9, with C. elegans coding bias and synthetic C. elegans introns, using the C. elegans Codon Adaptor 40 . Our Cas9 sequence includes a nuclear localization signal and an HA tag at the C terminus. The synthetic gene was produced as a series of overlapping 500-bp gBlocks (Integrated DNA Technologies), assembled using Gibson Assembly (New England BioLabs) and inserted into the vector pCFJ601 (Peft-3øMos1 Transposaseøtbb-2-3′ UTR) 17 in place of the Mos1 transposase. Next, a gBlock containing the U6 promoter and sgRNA sequence was inserted 3′ of the tbb-2 3′ UTR. Genomic targets of Cas9 conform to the target sequence GN 19 NGG, where N is any base. The initial G is a requirement for transcription initiation by the U6 promoter, and the NGG (PAM) motif is required for Cas9 activity (note that the NGG motif must be present in the genomic target but is not included in the sgRNA sequence). To target Cas9 to different genomic sequences, we inserted the desired targeting sequence into the Cas9-sgRNA construct using the Q5 site-directed mutagenesis kit (New England BioLabs) with forward primer 5′-N 19 GTTTTAGAGCTAGAAATAGCAAGT-3′, where N 19 is replaced by the desired 19-bp targeting sequence, and reverse primer 5′-CAAGACATCTCGCAATAGG-3′.
Supplementary Table 5 lists the targeting sequences used in this study.
Targeting vectors for single-copy transgene insertion on chromosome II were constructed in the pCFJ150 vector backbone 20 using Gateway cloning. We used site-directed mutagenesis with the Q5 site-directed mutagenesis kit to delete a short region of the 3′ recombination arm comprising the Cas9 target sequence to prevent the homologous repair templates from being cleaved by Cas9.
Homologous repair templates for gfp insertion and lin-31 mutagenesis were constructed in two steps. First, we PCR-amplified a 3-to 4-kb region centered on the desired modification from N2 genomic DNA and cloned the resulting fragment into the pCR-Blunt vector using the ZeroBlunt TOPO Cloning Kit (Life Technologies). Second, we modified this genomic clone by inserting gfp (for gfp knock-ins) or a 3′ exon containing point mutations (for lin-31 mutagenesis), along with the unc-119(+) rescue gene flanked by loxP sites. gfp and unc-119(+) fragments were generated by PCR, and LoxP sites were included in the unc-119(+) primers. The mutated lin-31 3′ exons were synthesized as gBlocks. These fragments were integrated into the genomic clones using Gibson assembly, which allows for seamless fusion of DNA fragments without the need to include any extra sequence (for example, restriction sites). To avoid cleavage of the repair templates by Cas9, we deleted or mutated the Cas9 target site in all repair templates. Complete plasmid sequences of all targeting vectors are available from the authors upon request.
To construct the Peft-3øCreøtbb-2-3′ UTR plasmid used for removal of selectable markers with Cre recombinase, we first amplified the Cre ORF from the plasmid pEM3 (ref. 41) and cloned it into the Gateway donor vector pDONR221. We then performed a three-fragment gateway reaction using our Cre donor vector, pCFJ386 (Peft-3; a gift from C. Frøkjaer-Jensen), pCM1.36 (tbb-2 3′ UTR) 42 and the destination vector pCFJ212 (ref. 17) , which contains an unc-119(+) rescue gene.
Supplementary Table 6 lists all primers used in this study.
Single-copy transgene insertion with MosSCI. We inserted transgenes into the ttTi5605 Mos1 site by following a published MosSCI protocol 17 . We prepared an injection mix containing 10 ng/µL targeting vector, 50 ng/µL pCFJ601 (Peft-3øMos1 Transposase), 10 ng/µL pMA122 (heat-shock driven PEEL-1 negative selection), 10 ng/µL pGH8 (Prab-3ømCherry neuronal co-injection marker), 5 ng/µL pCFJ104 (Pmyo-3ømCherry body-wall muscle co-injection marker) and 2.5 ng/µL pCFJ90 (Pmyo-2ømCherry pharyngeal co-injection marker). The mixture was microinjected into the gonads of Unc young adults of strain EG6699 (ttTi5605 II; unc-119(ed3) III), which were raised on HB101 bacteria at 15 °C. After injection, single worms were picked to new plates and maintained at 25 °C until starvation (10-12 d). Plates containing non-Unc worms were counted as successfully injected.
Occasionally, a batch of 50-60 injected animals yielded fewer than five successful injections, and we concluded that the injections had failed (usually for technical reasons, such as a bad needle) and repeated the injections. Following successful injections, we applied heat shock to plates with non-Unc worms at 34 °C for 4 h in an air incubator to activate the PEEL-1 negative-selection marker, which kills animals carrying extrachromosomal arrays. After overnight recovery at 25 °C, plates were visually screened to identify non-Unc animals that survived heat shock and did not express the red fluorescent co-injection markers. Single worms from these plates were picked to establish lines, and the presence of single-copy inserts was confirmed by PCR using primers listed in Supplementary Table 6 .
Cas9-triggered homologous recombination. To modify the genome using Cas9-triggered homologous recombination, we followed a protocol similar to that for MosSCI (above). A mix npg containing 10 ng/µL homologous repair template, 50 ng/µL Cas9-sgRNA plasmid, and the negative selection and co-injection markers listed above was injected into young adults of strain DP38 (unc-119(ed3) III) 43 . Note that although we used DP38 for the experiments reported in this study, we are recommending the use of the outcrossed derivative HT1593 for future experiments (see Supplementary Protocol) . The procedure for selecting insertions and eliminating extrachromosomal arrays was identical to that described above. We were able to isolate strains that were either homozygous or heterozygous for all of our modifications (D.J.D., unpublished observations); for the experiments presented in this study, only the homozygous lines were kept.
Removal of unc-119(+) using Cre recombinase. An injection mix containing 50 ng/µL of pDD104 (Peft-3øCreøtbb-2-3′ UTR) and 2.5 ng/µL pCFJ90 (Pmyo-2ømCherry pharyngeal marker) was injected into the gonads of young adult animals carrying an unc-119(+) cassette flanked by loxP sites. In each experiment, 15-20 animals were injected and placed at 25 °C. We picked single F 1 progeny (10-20 per experiment) expressing the red pharyngeal marker, which represent progeny of successful injections. We then selected Unc animals from among the F 2 progeny of these mCherry-positive animals. Because our Cre expression construct also carries unc-119(+), only animals that have (i) excised both genomic copies of the unc-119(+) cassette and (ii) lost the extrachromosomal array generated by injecting the Cre expression construct will be Unc. We verified that animals picked during this step were mCherry-negative and segregated only Unc progeny. Excision of unc-119(+) was then confirmed by PCR (see Fig. 3c ).
Antibodies and western blotting. Embryos were isolated from gravid adult worms by bleaching and were lysed by sonication for 20 min in a bath sonicator filled with boiling water. Lysates were separated on 3-8% NuPAGE Tris-acetate gels (Life Technologies) and transferred to nitrocellulose. The following antibodies were used: rabbit anti-NMY-2 (ref. 28) at 1:1,000 dilution of crude serum and Alexa Fluor 790 goat anti-rabbit (Life Technologies, catalog number A11369) at 1:1,000 dilution. Blots were scanned on an Odyssey imaging system (LI-COR Biosciences).
Microscopy. DIC and fluorescence imaging of whole worms was performed using a Nikon Eclipse E800 microscope equipped with epifluorescence and Nomarski DIC optics. Worms were mounted on 2.5% agar pads containing 10 mM sodium azide as a paralytic. For NMY-2-GFP imaging, early one-cell embryos were mounted on poly(l-lysine)-coated coverslips and gently flattened using 2.5% agar pads. Images were captured using a Nikon Eclipse Ti microscope equipped with a 60×, 1.4-NA objective and a Yokogawa CSU-X1 spinning disk head.
Maximum-intensity projection and adjustment of brightness and contrast were done using Fiji. No other image manipulations were performed. qRT-PCR. RNA was isolated from gravid adult worms as follows. Worms were picked into Trizol reagent (Life Technologies) and lysed by repeated freeze-thaw cycles. Chloroform was added to a final concentration of 20% to separate phases, and the upper aqueous phase was mixed with an equal volume of ethanol and loaded on a RNeasy spin column (Qiagen). On-column DNase digestion was performed with the Qiagen on-column DNase digestion kit, and then RNA was washed and eluted according to the manufacturer's instructions. 25-75 ng total RNA was used for cDNA synthesis with the Superscript III reverse transcriptase kit (Life Technologies). qPCR was performed using a Viia 7 realtime PCR instrument and SYBR Green PCR Master Mix (Life Technologies). his-72 transcripts were detected with forward primer 5′-TCGTTCGTGAGATTGCCCAG-3′ and reverse primer 5′-GAGTCCGACGAGGTATGCTT-3′. Y45F10D.4 was used for normalization 44, 45 . Data were analyzed to determine his-72 expression levels in Viia 7 software; we used the default settings for a relative standard-curve experiment.
Screening for off-target mutations induced by Cas9. Candidate off-target cleavage sites for each sgRNA were identified by BLAST searches 46 against the C. elegans genomic sequence. For each candidate off-target site, we PCR-amplified an ~1-kb fragment centered on the candidate site from genomic DNA isolated from N2 control animals and from each modified strain we generated. The PCR products were sequenced by Eton Bioscience using primers binding to each end of the fragment. The sequence reads were aligned to the genomic sequence to look for insertion or deletion mutations at the putative cleavage site.
Reproducibility. Our sample sizes were chosen to allow confidence in the results while maintaining feasibility, and they are consistent with established norms for C. elegans research and the developmental biology community more broadly. No randomization was necessary for these studies. Phenotypes presented in Figure 5d ,e were scored blindly.
